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STATE-OF-THE-ART PAPERS STATE-OF-THE-ART PAPERS1599CIMT: Promises for the FutureMichiel L. Bots, Kim Sutton-Tyrrell
Carotid intima-media thickness (CIMT) measurements have been used in cardiovascular
research for more than 2 decades. There is a wealth of evidence showing that CIMT can be
assessed in a reproducible manner and that increased CIMT relates to unfavorable risk factor
levels and the risk of future vascular events. Change in CIMT over time can be quantified
and this rate of change can be modified by treatment. The purpose of this report by Bots and
Sutton-Tyrrell is to address outstanding issues of how to measure CIMT and to suggest
promising areas for future studies using CIMT measurements in both research and clinical
practice.STATE-OF-THE-ART PAPERS1605Left Main Percutaneous Coronary InterventionPaul S. Teirstein, Matthew J. Price
The introduction of drug-eluting stents and advances in catheter technique have led to
increasing acceptance of percutaneous coronary intervention (PCI) as a viable alternative to
coronary artery bypass surgery (CABG) for unprotected left main disease. Current guidelines
recommend that unprotected left main PCI may be considered in patients with low-to-
intermediate anatomic complexity who are at increased surgical risk. Teirstein and Price
review the current data comparing PCI with CABG for left main disease, summarize recent
guideline recommendations, and provide an update on technical and pharmacologic
considerations to optimize clinical outcomes in left main PCI.(continued on page A-30)
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1614Are Asymptomatic Cerebral Embolic Complications
After Vascular Procedures Inconsequential?Daryl R. Gress
Recently cerebral embolic events have become a focus of clinical importance as complications
of vascular procedures. While relative safety of these procedures is usually defined by acute
stroke risk, far more subclinical events are occurring. Recent reports have provided substantial
evidence of memory loss, cognitive decline, and dementia related to these so-called “silent”
infarcts. Literature reports of magnetic resonance imaging events leads to an estimate of up to
600,000 patients with new brain injury each year in the United States alone. Given the
magnitude of the numbers involved, the impact of accelerated cognitive loss in a vulnerable
population could well be significant.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1617Score Predicts Risk of Stroke or Death After Carotid Artery StentingBeau M. Hawkins, Kevin F. Kennedy, Jay Giri, Adam J. Saltzman, Kenneth Rosenfield,
Douglas E. Drachman, Christopher J. White, John A. Spertus, Robert W. Yeh
Hawkins and colleagues used data from the NCDR CARE Registry to develop and
internally validate a risk score to predict in-hospital stroke or death (S/D) following carotid
artery stenting (CAS). Over 11,000 patients receiving CAS were reviewed. Independent
predictors of S/D included impending major surgery, prior stroke, age, symptomatic lesion,
atrial fibrillation, and absence of prior ipsilateral carotid endarterectomy. The inclusion of
available angiographic variables did not improve model performance. The NCDR CAS score,
comprised of 6 clinical variables, predicts in-hospital S/D following CAS and may be useful
for patient selection or counseling prior to CAS.INTERVENTIONAL CARDIOLOGY
1623Benefits of Ticagrelor Compared to Clopidogrel in Patients Undergoing
CABG Include Lower Rates of Both Thrombotic and Bleeding ComplicationsChristoph Varenhorst, Ulrica Alström, Benjamin M. Scirica, Charles W. Hogue, Nils Åsenblad,
Robert F. Storey, Ph. Gabriel Steg, Jay Horrow, Richard C. Becker, Stefan James,
Christopher P. Cannon, Gunnar Brandrup-Wognsen, Lars Wallentin, Claes Held
In the PLATO trial, patients assigned to ticagrelor compared to clopidogrel who underwent
coronary artery bypass graft surgery (CABG) had significantly lower total and cardiovascular
mortality. Alström and colleagues investigated the etiology of this differential. Numerically
more deaths occurred in the clopidogrel versus the ticagrelor group related to myocardial
infarction (14 vs. 10), heart failure (9 vs. 6), and arrhythmia or sudden death (9 vs. 3).
Clopidogrel was also associated with numerically higher bleeding (27 vs. 9), including
hemorrhagic stroke (7 vs. 2). The mortality reduction with ticagrelor versus clopidogrel
following CABG was due to fewer deaths from both cardiovascular and bleeding.(continued on page A-32)
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ECARDIOMETABOLIC RISK
1631Resolution of Youth Metabolic Syndrome
Lower the Future Risk of Diabetes and High CIMTCostan G. Magnussen, Juha Koskinen, Markus Juonala, Wei Chen, Sathanur R. Srinivasan,
Matthew A. Sabin, Russell Thomson, Michael D. Schmidt, Quoc Manh Nguyen, Ji-Hua Xu,
Michael R. Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen, Terho Lehtimäki, Tapani Rönnemaa,
Jorma S.A. Viikari, Gerald S. Berenson, Olli T. Raitakari
Youth with metabolic syndrome (MetS) are at increased risk of cardio-metabolic outcomes in
adulthood, but it is not known if this risk is attenuated in those who resolve their MetS status.
Magnussen and colleagues reviewed data from prospective cohorts in Finland and Louisiana
where data was collected on subjects aged 9 to 18 and then again 14 to 27 years later. Those
with MetS in youth and adulthood were at 3.4 times the risk of having high carotid artery
intima-media thickness and 12.2 times the risk of having type 2 diabetes mellitus compared
to those that did not have MetS at either timepoint. Those that resolved their MetS status by
dulthood showed similar risk to those that did not have MetS at either timepoint.HEART FAILURE1640Small Reductions in the Rates of Diabetes Could Substantially Lower the Rates of CHFChristy L. Avery, Laura R. Loehr, Christopher Baggett, Patricia P. Chang, Anna M. Kucharska-Newton,
Kunihiro Matsushita, Wayne D. Rosamond, Gerardo Heiss
Avery and colleagues used data from the ARIC study to estimate the population burden of
heart failure and the influence of the modifiable risk factors cigarette smoking, diabetes,
elevated low density lipoproteins, hypertension, and obesity. Over an average of 17.6 years of
follow-up, 1 in 3 African American and 1 in 4 Caucasian participants were hospitalized with
heart failure. Of the 5 modifiable risk factors, the largest incidence rate difference was
observed for diabetes. Further analysis suggests that a 5% reduction in the prevalence of
diabetes would result in approximately 53 and 33 fewer incident heart failure hospitalizations
per 100,000 person-years in African Americans and Caucasians, respectively.HEART RHYTHM DISORDERS
1647Model Predicts Risk of Death in Medicare Patients
Undergoing Defibrillators for Primary Prevention of Sudden Cardiac DeathKenneth C. Bilchick, George J. Stukenborg, Sandeep Kamath, Alan Cheng
Implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death
improve survival, but there seems to be a patient subset with high mortality for whom an
ICD may offer minimal benefit. Bilchick and colleauges used data from a large development
cohort and an even larger validation cohort of Medicare beneficiaries who received primary
prevention ICDs. Over a median follow-up of 4 years, approximately 1/3 of the patients died.
A mathematical model identified seven relevant predictors of mortality: Age  75, NYHA
lass III, atrial fibrillation/out of rhythm, COPD, chronic kidney disease, Ejection fraction
20%, and Diabetes. Patients in the highest risk decile based on these “SHOCKED”
redictors had a 65% 3-year mortality rate. The authors provide a nomogram for survival
robabilities 1 to 4 years after ICD implantation.ditorial Comment: Alfred E. Buxton, p. 1656
(continued on page A-35)
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Berthold Stegemann, Tarek Haddad, Russell E. A. Smith, Sanjay K. Prasad
Leyva and colleagues sought to determine whether left ventricular midwall fibrosis, detected
by midwall hyperenhancement (MWHE) on late gadolinium enhancement cardiovascular
magnetic resonance, predicts mortality and morbidity in patients with dilated cardiomyopathy
(DCM). Amongst 97 patients with nonischemic DCM, the risk of mortality was 18.6 times
higher for those with MWHE than those without. The risk was similar to those with
ischemic DCM. Midwall fibrosis is an independent predictor of mortality and morbidity in
patients with DCM, with substantially higher risk of both pump failure and sudden cardiac
death than those with no MWHE.BIOMARKERS
1668MARKED Score Predicts 90-Day Mortality
in Patients Presenting to the ED With DyspneaLuc W. Eurlings, Sandra Sanders-van Wijk, Roland van Kimmenade, Aart Osinski, Lidwien van Helmond,
Maud Vallinga, Harry J. Crijns, Marja P. van Dieijen-Visser, Hans-Peter Brunner-La Rocca, Yigal M. Pinto
Eurlings and colleagues investigated 5 biomarkers with distinct pathophysiological
backgrounds for short-term risk stratification in 603 patients presenting with dyspnea. High-
sensitivity cardiac troponin T, high-sensitivity C-reactive protein, Cystatin-C, and N-terminal
pro-B-type natriuretic peptide were each independent predictors of 90-day all-cause mortality
and the risk increased substantially as more biomarkers were elevated. From this data, a
simple scoring algorithm was developed for short-term risk stratification based on biomarkers
and clinical risk factors. This MARKED-risk score is able to identify patients with very low,
intermediate, and high risk for both short- and long-term mortality.GENETICS AND GENOMICS
1678Genetic Variation in the Promoter Region for NPY
May Influence Blood PressureKuixing Zhang, Fangwen Rao, Jose Pablo Miramontes-Gonzalez, C. Makena Hightower, Brian Vaught,
Yuhong Chen, Tiffany A. Greenwood, Andrew J. Schork, Lei Wang, Manjula Mahata, Mats Stridsberg,
Srikrishna Khandrika, Nilima Biswas, Maple M. Fung, Jill Waalen, Rita P. Middelberg, Andrew C. Heath,
Grant W. Montgomery, Nicholas G. Martin, John P. Whitfield, Dewleen G. Baker, Nicholas J. Schork,
Caroline M. Nievergelt, Daniel T. O’Connor
Neuropeptide Y (NPY) is a potent pressor peptide co-released with catecholamines during stress.
Zhang and colleagues began with genome-side linkage studies showing that variation at the NPY
locus itself determines NPY secretion. Then systematic polymorphism determination throughout
the gene was performed, which identified an insertion/deletion polymorhpism in the promoter
region of the gene. This polymorphism was found to predict higher NPY secretion as well as the
blood pressure response to environmental (cold) stress. In another population, this polymorphism
was was associated with a higher risk of hypertension and accounted for 4.5/2.1 mm Hg sys-
tolic blood pressure/diastolic blood pressure. Further studies showed that this polymorphism inter-
rupts a novel glucococortid response element motif, thereby affecting its rate of transcription.(continued on page A-36)
OCTOBER 23, 2012 (continued) A-36PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH1690Detection of Antecedent Myocardial Ischemia With Multi-Selectin Molecular ImagingBrian P. Davidson, Beat A. Kaufmann, J. Todd Belcik, Aris Xie, Qi Yue, Jonathan R. Lindner
Davidson and colleagues sought to develop an echocardiographic molecular imaging approach
for detecting antecedent myocardial ischemia by using recombinant P-selectin glycoprotein
ligand (PSGL)-1 as a targeting ligand. This technique relies on the fact that certain selectins
are exposed by endothelial cells during and after ischemia. Lipid microbubbles bearing
recombinant human PSGL-1 (MBYSPSL) were produced and targeted attachment was
confirmed by flow chamber and intravital microscopy. After brief LAD occlusion, MBYSPSL
produced strong signal enhancement at 90 min and 3 hrs after ischemia which spatially
correlated with the post-ischemic risk area. This imaging strategy offers a potentially useful
rapid bedside test for myocardial ischemia, even if it has resolved.PRE-CLINICAL RESEARCH1698Antiarrhythmic Potential of MSCs Is Modulated by Their EnvironmentHye Jin Hwang, Woochul Chang, Byeong-Wook Song, Heesang Song, Min-Ji Cha, Il-Kwon Kim,
Soyeon Lim, Eun Ju Choi, Onju Ham, Se-Yeon Lee, Jaemin Shim, Boyoung Joung, Hui-Nam Pak,
Sung Soon Kim, Bum-Rak Choi, Yangsoo Jang, Moon-Hyoung Lee, Ki-Chul Hwang
Hwang and colleagues investigated whether paracrine factors released from mesenchymal
stem cells (MSCs) modulate the electrophysiological properties of the border or ischemic
zone after injection into infarcted myocardium. After harvesting, MSCs were exposed to
either hypoxia or normoxia and the paracrine media from the cell culture was collected and
injected into the border zone of infarcted myocardium in rats. The injection of hypoxic PM,
but not normoxic PM, restored conduction velocities, suppressed focal activity, and prevented
sudden arrhythmic deaths in rats. These results suggest that a hypoxic or normoxic
environment surrounding MSCs affects the type and properties of the secreted growth factors
and cytokines, which can have profound effects on the surrounding myocardium.Editorial Comment: Eduardo Marba´n, Hee Cheol Cho, Eugenio Cingolani, p. 1707
